Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review, 8662 [2015-03256]
Download as PDF
<![CDATA[
8662
Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2015–03252 Filed 2–17–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Establishing a Vision and Eye
Health Surveillance System for the
Nation, DP15–004, initial review.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 10:00 a.m.–5:00 p.m.,
March 10, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)
(4) and (6), title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Establishing a Vision and Eye Health
Surveillance System for the Nation,
DP15–004, initial review.’’
Contact Person for More Information:
M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway NE., Mailstop F–80, Atlanta,
Georgia 30341, Telephone: (770) 488–
3585, EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–03256 Filed 2–17–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
OMB No.: OMB No: 0970–265.
Description: The Department of
Health and Human Services (HHS),
Administration for Children and
Families (ACF) proposes to revise the
ANA Reviewer Profile for Panel Review
Participation Form. The ANA Reviewer
Profile for Panel Review Participation
Form is used to collect information from
prospective proposal reviewers in
compliance with 42 U.S.C. 2991d 1.
First time reviewers will be required to
complete all sections of the form while
returning reviewers will be required to
complete the first section of the
document and other necessary updates.
The form allows the Commissioner of
ANA to select qualified people to
review grant applications submitted in
response to funding opportunity
announcements for ANA’s primary
programs: Social and Economic
Development Strategies (SEDS); Native
Language Preservation and
Maintenance; and Environmental
Regulatory Enhancement. The panel
review process is a legislative mandate
in the ANA grant funding process.
Respondents: All US citizens
including: Native Americans, Native
Alaskans, Native Hawaiians and other
Pacific Islanders.
Proposed Information Collection
Activity: Comment Request
Title: ANA Reviewer Profile for Panel
Review Participation Form.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ANA Consultant and Evaluator Qualifications Form .......................................
emcdonald on DSK67QTVN1PROD with NOTICES
Instrument
300
1
.5
150
Estimated Total Annual Burden
Hours: 150.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
VerDate Sep<11>2014
20:47 Feb 17, 2015
Jkt 235001
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
PO 00000
Frm 00074
Fmt 4703
Sfmt 9990
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Report Clearance Officer.
[FR Doc. 2015–03302 Filed 2–17–15; 8:45 am]
BILLING CODE 4184–01–P
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 80, Number 32 (Wednesday, February 18, 2015)]
[Notices]
[Page 8662]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03256]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Establishing a Vision and Eye
Health Surveillance System for the Nation, DP15-004, initial review.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 10:00 a.m.-5:00 p.m., March 10, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Establishing a Vision and Eye Health Surveillance System for the
Nation, DP15-004, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80,
Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-03256 Filed 2-17-15; 8:45 am]
BILLING CODE 4163-18-P
